Method of measuring regional tissue blood flow

• US 5,135,000 A
• Filed: 09/17/1991
• Issued: 08/04/1992
• Est. Priority Date: 09/19/1990
• Status: Expired due to Term

• Current Assignee: Ramot University Authority For Applied Research and Industrial Development Limited
• Original Assignee: Raizot University Authority For Applied Research & Industrial Development Limited
• Inventors: David, Daniel, Mor-Avi, Victor, Akselrod, Solange
• Primary Examiner(s): Jaworski, Francis
• Assistant Examiner(s): MANUEL, GEORGE C
• Application Number:
  US07/761,147
• Time in Patent Office: 322 Days
• Field of Search: 128/660.05, 128/661.08, 128/661.04, 128/662.05, 128/662.02
• US Class Current: 600/458
• CPC Class Codes: A61B 8/06 Measuring blood flow measuring volume flow in general G01F, e.g. G01F1/66, G01F1/72; measuring speed of fluids in general G01P5/00
• CPC Class Codes: A61B 8/481 involving the use of contrast agent, e.g. microbubbles introduced into the bloodstream analysis of echo signal exploiting properties of a contrast enhancer in devices for short-range imaging with acoustic waves G01S7/52039
• CPC Class Codes: G01S 15/8979 Combined Doppler and pulse-echo imaging systems

Abstract

A method of measuring blood flow through tissue in a region of interest including the steps: injecting an ultrasonic tracer into the blood upstream of the region of interest and also upstream of a specified reference region; utilizing the tracer-produced echo intensity function to compute: (i) the mean transit time of the tracer through the region of interest; and (ii) the blood volume within the region of interest; and dividing the results of computation (ii) by computation (i) to produce a quantitative measurement of the blood flow through the tissue in the region of interest.

Claims

1. A method of measuring blood flow through the tissue in a region of interest, comprising the following steps:

(a) injecting an ultrasonic tracer substance into the blood upstream of the region of interest and also upstream of a specified reference region;

(b) subjecting the region of interest and the specified reference region to ultrasonic waves;

(c) simultaneously detecting the echo intensity at the region of interest and the reference region at the same phase of a series of successive heartbeats, to produce echo intensity values as a function of time for the region of interest and for the reference region;

(d) measuring the mean background value in each region before the injection, and subtracting the mean background values from the detected echo intensity values at both regions to produce a measurement of the tracer-produced echo intensity functions;

(e) utilizing said latter echo intensity functions to compute;

(i) the mean transit time of the tracer through the region of interest; and

(ii) the blood volume within the region of interest;

(f) dividing the results of (e) (ii) by (e) (i) to produce a quantitative measurement of the blood flow through the tissue in the region of interest.

2. The method according to claim 1, wherein:

the mean transit time of the tracer through the region of interest in step (e) (i) is computed by;

(a) transforming the tracer-produced echo intensity functions in each region from the time domain to the frequency domain to produce a frequency domain intensity function for each region;

(b) dividing the frequency domain intensity function in the region of interest by the frequency domain intensity function in the reference region to produce the transfer function of the tissue in the region of interest;

(c) transforming the transfer function of the region of interest from the frequency domain to the time domain to produce the response function of the tissue in the region of interest;

(d) and utilizing the latter response function to compute the mean transit time of the tracer through the tissue in the region of interest.

3. The method according to claim 1, wherein the blood volume within the region of interest in step (e) (ii) is computed by:

(a) integrating with respect to time the tracer-produced echo intensity functions in the region of interest and in the reference region; and

(b) dividing the former by the latter to produce a measurement of the fractional blood volume within the tissue in the region of interest, which when divided by the mean transit time, produces a quantitative measurement of the blood flow through the tissue per unit mass of the tissue (in ml/gr/min or other equivalent units).

4. The method according to claim 1, wherein said tracer substance is a solution containing microscopic particles, about the size of the red blood cells, capable of enhancing the intensity of the ultrasonic reflection.

5. The method according to claim 1, wherein in step (b), the region of interest and the specified reference region, are subjected to the two-dimensional ultrasonic imaging, and the acquired images are processed to produce a regional video intensity independent of tracer concentration in the surrounding regions.

6. The method according to claim 5, wherein the acquired images are processed to produce a regional video intensity independent of tracer concentration in the surrounding regions by subjecting said acquired images to digital path dependent time-gain recompensation.

7. A method of measuring blood flow through the tissue in a region of interest, comprising the steps:

(a) injecting an ultrasonic tracer substance into the blood upstream of the region of interest and also upstream of a specified reference region;

(b) subjecting the region of interest and the specified reference region to two-dimensional ultrasonic imaging, and processing the acquired images to produce a regional video intensity independent of tracer concentration in the surrounding region;

(c) simultaneously detecting the echo intensity at the region of interest and the reference region at the same phase of a series of successive heartbeats, to produce echo intensity values as a function of time for the region of interest and for the reference region;

(d) measuring the mean background value in each region before the injection, and subtracting the mean background values from the detected echo intensity values at both regions to produce a measurement of the tracer-produced echo intensity functions;

(e) utilizing said measurement to compute;

(i) the mean transit time of the tracer through the region of interest; and

(ii) the blood volume within the region of interest;

(f) dividing the results of (e) (ii) by (e) (i) to produce a quantitative measurement of the blood flow through the tissue in the region of interest.

8. The method according to claim 7, wherein:

the mean transit time of the tracer through the region of interest n step (e) (i) is computed by;

(a) transforming the tracer-produced echo intensity functions in each region from the time domain to the frequency domain to produce a frequency domain intensity function for each region;

(b) dividing the frequency domain intensity function in the region of interest by the frequency domain intensity function in the reference region to produce the transfer function of the tissue in the region of interest;

(c) transforming the transfer function of the region of interest from the frequency domain to the time domain to produce the response function of the tissue in the region of interest;

(d) and utilizing the latter response function to compute the mean transit time of the tracer through the tissue in the region of interest.

9. The method according to claim 8, wherein the blood volume within the region of interest in step (e) (ii) is computed by:

(a) integrating with respect to time the tracer-produced echo intensity functions in the region of interest and in the reference region; and

(b) dividing the former by the latter to produce a measurement of the fractional blood volume within the tissue in the region of interest, which, when divided by the mean transit time, produces a quantitative measurement of the blood flow through the tissue per unit mass of the tissue (in ml/gr/min or other equivalent units).

10. The method according to claim 7, wherein said tracer substance is a solution containing microscopic particles, about the size of the red blood cells, capable of enhancing the intensity of the ultrasonic reflection.